Biomarin Pharmaceutical reported $196.83M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Amgen AMGN:US $ 1.33B 99M
Bayer BAYN:GR 4.47B 527M
Biogen BIIB:US $ 572.6M 62.3M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Gilead Sciences GILD:US $ 1.36B 274M
Insmed INSM:US $ 59.97M 3.23M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
Moderna Inc MRNA:US 211M 57M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Puma Biotechnology PBYI:US $ 20.58M 174K
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sangamo Biosciences SGMO:US $ 15.09M 185K
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Seattle Genetics SGEN:US $ 220.26M 46.03M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
United Therapeutics UTHR:US $ 141.5M 62.5M
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
YTE INCY:US $ 253.28M 43.69M